急性前壁心梗急诊冠脉介入治疗时间窗差异对患者疗效的影响分析  

Analysis of the effect of different time windows of emergency percutaneous coronary intervention on patients with acute anterior myocardial infarction

作　　者：林进爵 LIN Jin-jue(Suixi Hospital,Affiliated Hospital of Guangdong Medical University,Zhanjiang 524300,China)

机构地区：[1]广东医科大学附属医院遂溪医院,524300

出　　处：《中国实用医药》2024年第22期104-107,共4页China Practical Medicine

摘　　要：目的 探讨急性前壁心肌梗死(心梗)急诊冠状动脉(冠脉)介入治疗时间窗差异对患者疗效的影响。方法 选取60例接受急诊冠脉介入治疗的急性前壁心梗患者,采取随机数字表法分为对照组与试验组,各30例。对照组于发病3 h后接受治疗,试验组于发病3 h内接受治疗。比较两组治疗前后心功能指标及治疗后生活质量评分、术后不良心血管事件发作次数、治疗效果、不良心血管事件发生率。结果 治疗后,试验组左心室舒张末期内径(LVEDD)(51.15±4.73)mm、左心室收缩末期内径(LVESD)(40.21±5.16)mm均小于对照组的(57.21±4.79)、(43.85±5.72)mm,左心室射血分数(LVEF)(42.52±5.18)%大于对照组的(36.15±5.82)%(P<0.05)。试验组治疗后躯体功能、心理功能、生理功能、社会功能评分分别为(72.49±5.46)、(73.42±6.03)、(71.52±5.56)、(78.42±6.71)分,均明显高于对照组的(61.48±4.48)、(62.53±5.41)、(60.03±5.03)、(66.47±6.28)分(P<0.05)。试验组心律失常、心力衰竭、心绞痛、心源性休克发作次数分别为(1.61±0.32)、(0.47±0.02)、(1.36±0.45)、(0.89±0.24)次/月,均少于对照组的(3.03±0.39)、(1.96±0.09)、(3.63±0.83)、(2.39±0.65)次/月(P<0.05)。试验组的临床治疗总有效率96.67%明显高于对照组的73.33%(P<0.05)。试验组不良心血管事件发生率6.67%低于对照组的26.67%(P<0.05)。结论 针对急性前壁心肌梗死患者的治疗时间窗,相比于发病3 h后,发病3 h内实施急诊冠脉介入治疗可获得获得良好的疗效。Objective To explore the effect of different time windows of emergency percutaneous coronary intervention on patients with acute anterior myocardial infarction.Methods 60 patients with acute anterior myocardial infarction who received emergency percutaneous coronary intervention were divided into a control group and an experimental group by random numerical table,with 30 cases in each group.The control group received treatment 3 h after the onset of the disease,and the experimental group received treatment within 3 h of the onset of the disease.The cardiac function indicators before and after treatment,and quality of life score after treatment,number of episodes of postoperative adverse cardiovascular events,therapeutic effect and incidence of adverse cardiovascular events were compared between the two groups.Results After treatment,the left ventricular end-diastolic diameter(LVEDD) and left ventricular end-systolic diameter(LVESD) of the experimental group were(51.15±4.73) mm and(40.21±5.16) mm,which were smaller than(57.21±4.79) and(43.85±5.72) mm of the control group;the left ventricular ejection fraction(LVEF) of(42.52±5.18) % of the experimental group was higher than(36.15±5.82) % of the control group(P<0.05).After treatment,the scores of physical function,psychological function,physiological function and social function were(72.49±5.46),(73.42±6.03),(71.52±5.56) and(78.42±6.71) points in the experimental group,which were significantly higher than(61.48±4.48),(62.53±5.41),(60.03±5.03) and(66.47±6.28) points in the control group(P<0.05).The number of episodes of arrhythmia,heart failure,angina pectoris,and cardiogenic shock were(1.61±0.32),(0.47±0.02),(1.36±0.45),and(0.89±0.24) times/month in the experimental group,which were fewer than(3.03±0.39),(1.96±0.09),(3.63±0.83),and(2.39± 0.65) times/month in the control group(P<0.05).The total effective rate of clinical treatment was 96.67% in the experimental group,which was significantly higher than 73.33% in the control group(P<0.05).The inc

关 键 词：急性前壁心肌梗死 急诊冠状动脉介入治疗 时间窗差异 疗效 

分 类 号：R542.22[医药卫生—心血管疾病]